Evidence map›Paper›PMID 37728284›Full record

ArticleJournal of neurosurgery. Case lessons2023

Slow-growing WNT medulloblastoma with atypical magnetic resonance imaging findings: illustrative case.

Makoto Mizushima, Michinari Okamoto, Shigeru Yamaguchi, Sogo Oki, Hiroaki Motegi, Minako Sugiyama, Atsushi Manabe, Ai Shimizu, Kentaro Nishioka, Takayuki Hashimoto and 3 more

Abstract read
In one paragraph

Article in Journal of neurosurgery. Case lessons, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Makoto Mizushima1Department of Neurosurgery, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
Michinari Okamoto1Department of Neurosurgery, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
Shigeru Yamaguchi1Department of Neurosurgery, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
Sogo Oki1Department of Neurosurgery, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
Hiroaki Motegi1Department of Neurosurgery, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
Minako Sugiyama2Department of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
Atsushi Manabe2Department of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
Ai Shimizu3Department of Surgical Pathology, Hokkaido University Hospital, Sapporo, Hokkaido, Japan.
Kentaro Nishioka4Department of Radiation Oncology, Hokkaido University Hospital, Sapporo, Hokkaido, Japan.
Takayuki Hashimoto4Department of Radiation Oncology, Hokkaido University Hospital, Sapporo, Hokkaido, Japan.
Junko Hirato5Department of Pathology, Public Tomioka General Hospital, Gunma, Japan; and.
Yonehiro Kanemura6Department of Biomedical Research and Innovation, Institute for Clinical Research, National Hospital Organization Osaka National Hospital, Osaka, Japan.
Miki Fujimura1Department of Neurosurgery, Hokkaido University Graduate School of Medicine, Sapporo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMedulloblastomas, with four molecular subgroups, are generally rapid-growing tumors with significant contrast enhancement and well-defined margins. However, each subgroup's clinical features, including disease time course and imaging characteristics, are not well defined. OBSERVATIONS: The authors describe the case of a 15-year-old female who presented with a 7-month history of impaired left-hand movement and was found to have a lesion on the dorsal side of the fourth ventricle. T2-weighted magnetic resonance imaging (MRI) at the patient's first presentation showed diffuse hyperintense signal without apparent mass, and gadolinium-enhanced T1-weighted imaging showed very slight contrast enhancement. In 1 month, her symptoms progressed, and follow-up MRI revealed an increase in the size of the lesion, showing greater diffusion restriction and contrast enhancement. She underwent gross-total resection, and pathology was consistent with classic medulloblastoma. Genetic analysis of the tumor confirmed the wingless (WNT) molecular subgroup. Adjuvant chemotherapy and proton beam therapy were performed. At the 18-month follow-up, MRI showed no recurrence of disease. LESSONS: Slow-growing medulloblastoma is very rare and not known to be associated with a specific molecular subgroup. Here, the authors report a case of slow-growing WNT medulloblastoma, indicating that slow growth may be a feature of this subgroup.

Indexed as

medulloblastomaMRI diagnosticsWnt signaling

Identifiers

PMID37728284
PMCPMC10555650

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.